Standard Biotools

Standard Biotools

LAB· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -26.9% in FY2025

Michael Egholm, Ph.D. is the CEO of Standard Biotools and was paid $8.8M in FY2025 (Dec), up 6%.

Pay$100 in the stock at the end of FY21 → $33
CEO pay is from each Standard Biotools proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Michael Egholm, Ph.D.FY2025
  2. 2Alex KimFY2025
  3. 3Sean MackayFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Standard Biotools paid its 3 named executives $14.5M in total in FY2025 (Dec). CEO Michael Egholm, Ph.D. was paid $8.8M of that.

Name
Michael Egholm, Ph.D.President, Chief Executive Officer, and Director
Alex KimChief Financial Officer
Sean MackayChief Business Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers22

See all

The FY2025 (Dec) proxy of Standard Biotools names 22 peer companies for pay. Among Standard Biotools and these peers, CEO pay was 5th highest of 13 and total shareholder return was 11th highest of 13.

5th highest of 13in Standard Biotools and its pay peers, FY2025 (Dec) by CEO pay:

$2.4M$23.2M

11th highest of 13in Standard Biotools and its pay peers, FY2025 (Dec) by total shareholder return:

$7$495

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board5

See all
  • Thomas CareyChair · 1 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
  • Eli CasdinDirector · 3 yr on the boardIndependentHuman Capital, Nominating and Corporate Governance—Paid as an executive
  • Frank WitneyDirector · 3 yr on the boardIndependentAudit, Human Capital (Chair)—Paid as an executive
  • Fenel M. EloiDirector · 2 yr on the boardIndependentAudit (Chair)—Paid as an executive
  • Kathy HibbsDirector · 1 yr on the boardIndependentAudit, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2025).

Shared directors

Activity

  1. Pay
    Standard Biotools Division head pay fell 47% to $1.7M. The stock fell 27% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Standard Biotools CEO pay fell 88% to $1.9M. The stock rose 89% in FY2023 (Dec).
    DEF 14A
  3. Pay
    Standard Biotools CFO pay rose 30% to $4.0M. The stock fell 27% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Standard Biotools CFO pay fell 84% to $909.8K. The stock rose 89% in FY2023 (Dec).
    DEF 14A
  5. Pay
    Standard Biotools CEO pay rose 332% to $8.3M. The stock fell 21% in FY2024 (Dec).
    DEF 14A
  6. Pay
    Standard Biotools Former CFO pay rose 27% to $1.9M. The stock fell 21% in FY2024 (Dec).
    DEF 14A
  7. Pay
    Standard Biotools CFO pay rose 240% to $3.1M. The stock fell 21% in FY2024 (Dec).
    DEF 14A
  8. Board
    Thomas Carey joined the board of Standard Biotools. Thomas Carey sits on no other public board.
    3
  9. Board
    Kathy Hibbs joined the board of Standard Biotools. Kathy Hibbs now sits on 2 public boards.
    3

Filings5

See all
Proxy statementDEF 14AApr 27, 2026FY2025
Annual report10-KMar 16, 2026FY2025
Proxy statementDEF 14AApr 30, 2025FY2024
Annual report10-KMar 11, 2025FY2024
Annual report10-KMar 1, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data